Go Back

Yamin ‘Mo’ Khan

Non-Executive Director

Yamin Mo Khan

Yamin ‘Mo’ Khan is a Non-Executive Director of Open Orphan with over 25 years of experience in clinical research and the CRO industry. Mo currently works as a Consultant assisting CROs to develop growth strategies and helping prepare companies for future expansion, both organic and through M&A activity. In addition Mo works with Private Equity firms providing insight in identifying potential targets and conducting due diligence in preparation for M&A activity. Prior to this Mo had a variety of senior roles at Pharm-Olam where he played a pivotal role in growing a small niche clinical monitoring business to a global full-service CRO with offices across all continents. In his time at Pharm-Olam Mo had leading roles in Clinical Operations, Project Management, Business Development and Executive Management functions. As a key member of the Executive Team Mo participated in the successful sale of the company in 2017, delivering substantial returns to its shareholders. Prior to this he worked at Innovex and Quintiles (IQVIA).

Mo holds a PhD in Biochemistry from the University of Southampton, UK, and a Bachelor’s degree in Biochemistry from the University of Liverpool, UK.